US health system ranks last compared with peer nations – report

Original Article ↗ Hacker News Discussion ↗

A new international ranking placing the U.S. health system last among rich nations prompts sharp contrasts between American care and systems in Europe and Asia. Commenters highlight the U.S. mix of very high spending, patchy insurance coverage, medical debt, and delayed or denied non-emergency care, while noting that outcomes often fail to justify the costs. Others point out that public systems like the UK’s NHS and various European models also struggle with long waits and underfunding, but generally deliver broader, more affordable access and better average health outcomes.

Structure of US Healthcare & Access Gaps

  • Described as a patchwork: Medicare (elderly), Medicaid/CHIP (low income, state-run), employer insurance, ACA marketplace, plus private cash/self-pay.
  • Significant holes: part-time and gig workers, small-business owners, people unable to navigate complex paperwork.
  • Federal EMTALA requires ERs to screen/stabilize emergencies, but:
    • Many commenters stress this does not guarantee full treatment, surgery, chemo, or routine care without payment.
    • Others report hospitals informally “just treat everyone,” but this is disputed as atypical or lucky experience.

Quality, Outcomes, and Inequality in the US

  • Broad agreement: care can be excellent for the rich or well‑insured, and abysmal or inaccessible for the poor or underinsured.
  • Some argue US outcomes (e.g., cancer survival) can be better than Europe’s for serious cases; others counter with references to poor life expectancy and high medical debt.
  • Many report long waits even with “good” insurance for primary care, specialists, imaging, and insurer approvals.

Comparisons with Other Countries

  • UK/NHS
    • Some high earners rely mainly on NHS and find it adequate, using cheap private services mainly to skip queues.
    • Others describe chronic underfunding, very long waits (including for serious conditions), and worsening outcomes; see the NHS as “safety net only.”
    • Debate over whether criticism is politically exaggerated vs reflecting real systemic crisis.
  • Continental Europe
    • Reports of faster diagnostics and broad coverage in places like France, Germany, Switzerland, Spain, Croatia, but also long waits for non‑urgent care or certain specialties.
    • Several systems mix mandatory public insurance with strong private sectors; co-pays are small compared to US prices.
  • Asia / Global South
    • India, Thailand, Taiwan, Mexico, Philippines, Ukraine noted for rapid diagnostics (often same day) and much lower costs.
    • Some question quality parity; others say these systems have caught issues missed in the US.
  • Medical tourism (to Mexico, India, Thailand, UK, etc.) already used by some Americans.

ACA / Obamacare and Insurance Economics

  • ACA praised for:
    • Ending routine preexisting‑condition denials.
    • Enabling people with chronic conditions to leave jobs and start businesses.
  • Also criticized as:
    • A “corporate giveaway” that left premiums/deductibles very high and kept employer‑tied insurance.
    • Still causing job lock via COBRA costs and yearly deductible resets.
  • Pre‑ACA stories highlight extreme uninsurability, bankruptcy, and “wage slavery” tied to employer coverage.

Costs, Pharma, and “Paying for the World”

  • Consensus that US spends far more per capita yet gets mediocre or poor population‑level outcomes.
  • Some argue high US prices effectively fund global pharma R&D; others emphasize profit extraction by insurers, hospital chains, and drug companies.
  • Suggestions: allow drug importation, formalize medical tourism, push foreign systems to share more of R&D cost.

Data Systems, Privacy, and Administration

  • US electronic health records seen as fragmented, billing‑centric, and ergonomically poor; patients often ferry records manually.
  • Estonia’s unified national health record is held up as a successful model; concerns raised about cyber risk and misuse, but proponents cite strong safeguards and audit trails.
  • In the US and elsewhere, strict privacy rules can impede timely information sharing between providers, frustrating patients and clinicians.

Rankings, Methods, and Politics

  • Disagreement over international rankings:
    • Some trust studies that place the US last on cost–outcome efficiency.
    • Others dismiss certain sources (e.g., Wikipedia, Statista, some foundations) as biased or politically motivated.
  • Debate on whether comparisons should be US vs single nations or vs entire EU; also whether federal/state variation in US should be treated like EU country variation.
  • Political obstacles noted: lobbying, filibuster, ideological opposition to “socialized” care, and deliberate underfunding of public systems (e.g., NHS) to justify privatization.